Mechanistically, both ITD and TKD mutations result in constitutive activation of FLT3 signalling, hence the cellular proliferation, anti-apoptosis and differentiation block that are often seen in FLT3 mutant AML cases [1,10]. The gene discussed is FLT3; the disease is acute myeloid leukemia.